2nd Quarter - Report

WILLIAMS AND JENSEN, PLLC for NOVARTIS INC

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety and drug counterfeiting; Drug importation; Authorized generics; Drug company settlements including S. 27, Preserve Access to Affordable Generics Act; Prescription drug advertising; Federal preemption for prescription drugs; implementation of the Patient Protection and Affordable Care Act; Reauthroization of the Prescription DrugUser Fee Act (FDA Safety and Innovation Act (S.3187)) and drug shortages.

LobbyistCovered position, as disclosed
JENNY DIJAMES New LA and LD, Rep. Bud Cramer
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA New —
KARINA LYNCH —
MELINDA M MAXFIELD New —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 27 (112th), S. 3187 (112th)

Medicare/Medicaid MMM

Medicare prescription drug benefit Rebates for Medicare Part D. Independent Payment Advisory Board (IPAB)

LobbyistCovered position, as disclosed
REBECCA ANDERSON New —
JENNY DIJAMES New —
SUSAN HIRSCHMANN —
KARINA LYNCH —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

Funding for pandemic influenza countermeasures

LobbyistCovered position, as disclosed
MATTHEW B HOEKSTRA New —
ERIN BOOK MULLEN —
GEORGE OLSEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.